"index","relation-type","term1","b1","e1","term2","b2","e2","sentence","job"
"1919","TWrex-treat","[VISCERAL LEISHMANIASIS]","61","83","[AMPHOTERICIN]","10","22","Liposomal [AMPHOTERICIN] B appears as an effective therapy for [VISCERAL LEISHMANIASIS] in children and could be used as a first-line treatment.","0"
"1920","TWrex-treat","[ANGINA]","25","31","[TRINITRATE]","243","253","Ten patients with stable [ANGINA] pectoris and obstructed coronary arteries (greater than 75% reduction in diameter) were studied before and during two periods of pacing, the second of which was preceded by sublingual administration of glyceryl [TRINITRATE] (mean dose 0.78 mg.","0"
"1921","TWrex-treat","[MYCOSIS]","78","85","[AMPHOTERICIN]","0","12","[AMPHOTERICIN] B (AmB) is a popular drug frequently applied in the treatment of [MYCOSIS].","0"
"1922","TWrex-treat","[FUNGAL INFECTION]","13","29","[AMPHOTERICIN]","75","87","For possible [FUNGAL INFECTION]s, empiric therapy with fluconazole (FLCZ) or [AMPHOTERICIN] B (AMPH) is recommended.","0"
"1923","TWrex-treat","[CARIES]","191","197","[FLUORIDE]","97","105","Teeth treated with microabrasion followed by a 4-minute application of 1% neutral topical sodium [FLUORIDE] exhibited significantly less enamel demineralization when subjected to an artificial [CARIES] challenge than did teeth that underwent microabrasion alone, topical fluoride treatment alone, or no treatment at all.","0"
"1924","TWrex-treat","[CARIES]","191","197","[FLUORIDE]","267","275","Teeth treated with microabrasion followed by a 4-minute application of 1% neutral topical sodium fluoride exhibited significantly less enamel demineralization when subjected to an artificial [CARIES] challenge than did teeth that underwent microabrasion alone, topical [FLUORIDE] treatment alone, or no treatment at all.","0"
"1926","TWrex-treat","[AMENORRHEA]","96","106","[BROMOCRIPTINE]","0","13","[BROMOCRIPTINE] therapy was effective in 54 of 84 cases (64%), including 6 of 15 (40%) cases with [AMENORRHEA], 16 of 24 cases (67%) with anovulatory cycle, 9 of 15 cases (60%) with delayed ovulation and 23 of 30 cases (77%) with luteal phase defect.","0"
"1927","TWrex-treat","[DIABETES]","229","237","[INSULIN]","24","31","Continuous subcutaneous [INSULIN] infusion (CSII) has been compared with conventional insulin injection treatment (CIT) supplemented by self-monitoring of capillary blood glucose (SMBG) in 18 nonobese adults with insulin-dependent [DIABETES] mellitus (IDDM.","0"
"1928","TWrex-treat","[DIABETES]","229","237","[INSULIN]","84","91","Continuous subcutaneous insulin infusion (CSII) has been compared with conventional [INSULIN] injection treatment (CIT) supplemented by self-monitoring of capillary blood glucose (SMBG) in 18 nonobese adults with insulin-dependent [DIABETES] mellitus (IDDM.","0"
"1929","TWrex-treat","[DIABETES]","229","237","[INSULIN]","211","218","Continuous subcutaneous insulin infusion (CSII) has been compared with conventional insulin injection treatment (CIT) supplemented by self-monitoring of capillary blood glucose (SMBG) in 18 nonobese adults with [INSULIN]-dependent [DIABETES] mellitus (IDDM.","0"
"1930","TWrex-treat","[SYNDROME]","210","218","[OXIDE]","15","20","Inhaled nitric [OXIDE] (NO) dilates pulmonary blood vessels and has been used to reduce pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension and acute respiratory distress [SYNDROME].","0"
"1931","TWrex-treat","[DISORDER]","87","95","[LITHIUM]","23","30","Medications, including [LITHIUM], have demonstrated efficacy in the treatment of bipolar [DISORDER], but their molecular targets and mode of action are largely unknown.","0"
"1932","TWrex-treat","[NIDDM]","215","220","[RELEASE]","97","104","Information concerning the loss of first-phase insulin secretion, altered pulsatility of insulin [RELEASE], and enhanced proinsulin-insulin secretory ratio is discussed as it pertains to altered beta-cell function in [NIDDM].","0"
"1933","TWrex-treat","[HYPOGLYCEMIA]","196","208","[GLUCOSE]","277","284","observation of acetonuria which is always absent after hypoglycemic episodes, 2, the typical constellation of insulin concentration, free fatty acid concentration and beta-hydroxybutyrat during a [HYPOGLYCEMIA] (as found by Baker et al. 1976) and/or by simultaneous measuring of [GLUCOSE]-insulin levels under the conditions of fasting as well as of oral leucine, oral glucose and intravenous tolbutamide loading.","0"
"1934","TWrex-treat","[HYPOGLYCEMIA]","196","208","[GLUCOSE]","365","372","observation of acetonuria which is always absent after hypoglycemic episodes, 2, the typical constellation of insulin concentration, free fatty acid concentration and beta-hydroxybutyrat during a [HYPOGLYCEMIA] (as found by Baker et al. 1976) and/or by simultaneous measuring of glucose-insulin levels under the conditions of fasting as well as of oral leucine, oral [GLUCOSE] and intravenous tolbutamide loading.","0"
"1935","TWrex-treat","[TRIGEMINAL NEURALGIA]","71","91","[CARBAMAZEPINE]","0","13","[CARBAMAZEPINE] continues to be the most useful drug in the treatment of [TRIGEMINAL NEURALGIA].","0"
"1936","TWrex-treat","[HYPERTENSION]","101","113","[LISINOPRIL]","28","38","Thus, captopril, enalapril, [LISINOPRIL] and ramipril can be used in the treatment of mild to moderate [HYPERTENSION] either alone or in conjunction with diuretics or calcium antagonists.","0"
"1938","TWrex-treat","[MALARIA]","45","52","[DRUG]","124","128","We recommend that young children with severe [MALARIA] be treated with broad-spectrum antibiotics in addition to antimalarial [DRUG]s.","0"
"1939","TWrex-treat","[MALARIA]","115","122","[DRUG]","124","128","We recommend that young children with severe malaria be treated with broad-spectrum antibiotics in addition to anti[MALARIA]l [DRUG]s.","0"
"1940","TWrex-treat","[HEPATITIS]","125","134","[ADEFOVIR DIPIVOXIL]","0","18","[ADEFOVIR DIPIVOXIL] is an important new addition to the current first-line treatments for HBeAg positive and negative chronic [HEPATITIS] B, as well as being rescue therapy for lamivudine-resistant HBV strains.","0"
"1941","TWrex-treat","[MELANOMA]","27","35","[ALFA]","155","159","Patients with disseminated [MELANOMA] should be treated with well-tolerated drug regimens, such as single-agent treatments or in combination with interferon [ALFA].","0"
"1942","TWrex-treat","[HEPATITIS]","11","20","[INTERFERON]","38","48","In chronic [HEPATITIS] C, the number of [INTERFERON]-gamma-producing Th cells was increased after incubation of the cells with interferon-alpha (P = 0.008) or with recombinant interferon-gammala (P = 0.024), but not with interferon-beta (P = 0.051.","0"
"1943","TWrex-treat","[HEPATITIS]","11","20","[INTERFERON]","123","133","In chronic [HEPATITIS] C, the number of interferon-gamma-producing Th cells was increased after incubation of the cells with [INTERFERON]-alpha (P = 0.008) or with recombinant interferon-gammala (P = 0.024), but not with interferon-beta (P = 0.051.","0"
"1944","TWrex-treat","[HEPATITIS]","11","20","[INTERFERON]","172","182","In chronic [HEPATITIS] C, the number of interferon-gamma-producing Th cells was increased after incubation of the cells with interferon-alpha (P = 0.008) or with recombinant [INTERFERON]-gammala (P = 0.024), but not with interferon-beta (P = 0.051.","0"
"1945","TWrex-treat","[HEPATITIS]","11","20","[INTERFERON]","217","227","In chronic [HEPATITIS] C, the number of interferon-gamma-producing Th cells was increased after incubation of the cells with interferon-alpha (P = 0.008) or with recombinant interferon-gammala (P = 0.024), but not with [INTERFERON]-beta (P = 0.051.","0"
"1946","TWrex-treat","[TREMOR]","30","36","[PROPRANOLOL]","0","11","[PROPRANOLOL] therapy decreased [TREMOR] more in the alcoholics than in essential tremor.","0"
"1947","TWrex-treat","[TREMOR]","78","84","[PROPRANOLOL]","0","11","[PROPRANOLOL] therapy decreased tremor more in the alcoholics than in essential [TREMOR].","0"
"1948","TWrex-treat","[HERPES SIMPLEX VIRUS INFECTION]","52","82","[ACICLOVIR]","0","9","[ACICLOVIR] is an efficient drug for the treatment of [HERPES SIMPLEX VIRUS INFECTION]s and resistance to this drug has been reported mainly in immunocompromised patients during the course of aciclovir treatment.","0"
"1949","TWrex-treat","[HERPES SIMPLEX VIRUS INFECTION]","52","82","[ACICLOVIR]","188","197","Aciclovir is an efficient drug for the treatment of [HERPES SIMPLEX VIRUS INFECTION]s and resistance to this drug has been reported mainly in immunocompromised patients during the course of [ACICLOVIR] treatment.","0"
"1950","TWrex-treat","[DISORDER]","317","325","[CLOMIPRAMINE]","73","85","The study confirms the previously reported effectiveness of low doses of [CLOMIPRAMINE] in the treatment of premenstrual syndrome and demonstrates that the time lag between onset of medication and clinical effect is shorter when clomipramine is used for premenstrual syndrome than when it is used for depression, panic [DISORDER], or obsessive compulsive disorder.","0"
"1951","TWrex-treat","[DISORDER]","317","325","[CLOMIPRAMINE]","227","239","The study confirms the previously reported effectiveness of low doses of clomipramine in the treatment of premenstrual syndrome and demonstrates that the time lag between onset of medication and clinical effect is shorter when [CLOMIPRAMINE] is used for premenstrual syndrome than when it is used for depression, panic [DISORDER], or obsessive compulsive disorder.","0"
"1952","TWrex-treat","[DISORDER]","351","359","[CLOMIPRAMINE]","73","85","The study confirms the previously reported effectiveness of low doses of [CLOMIPRAMINE] in the treatment of premenstrual syndrome and demonstrates that the time lag between onset of medication and clinical effect is shorter when clomipramine is used for premenstrual syndrome than when it is used for depression, panic disorder, or obsessive compulsive [DISORDER].","0"
"1953","TWrex-treat","[DISORDER]","351","359","[CLOMIPRAMINE]","227","239","The study confirms the previously reported effectiveness of low doses of clomipramine in the treatment of premenstrual syndrome and demonstrates that the time lag between onset of medication and clinical effect is shorter when [CLOMIPRAMINE] is used for premenstrual syndrome than when it is used for depression, panic disorder, or obsessive compulsive [DISORDER].","0"
"1958","TWrex-treat","[ULCER]","33","38","[RANITIDINE]","44","54","Maintenance therapy for duodenal [ULCER] with [RANITIDINE] 150 mg/day for one year is less expensive and more cost-effective than intermittent treatment.","0"
"1959","TWrex-treat","[CARCINOMA]","91","100","[INTERFERON]","14","24","In conclusion [INTERFERON] is one of the most valuable agents in the treatment of renal cell [CARCINOMA].","0"
"1960","TWrex-treat","[SEPSIS]","215","221","[PIPERACILLIN]","120","132","The objectives of this study were (i) to compare the plasma concentration-time profiles for first-dose and steady-state [PIPERACILLIN] administered by intermittent or continuous dosing to critically ill patients with [SEPSIS] and (ii) to use population pharmacokinetics to perform Monte Carlo dosing simulations in order to assess the probability of target attainment (PTA) by minimum inhibitory concentration (MIC) for different piperacillin dosing regimens against bacterial pathogens commonly encountered in critical care units.","0"
"1961","TWrex-treat","[SEPSIS]","215","221","[PIPERACILLIN]","426","438","The objectives of this study were (i) to compare the plasma concentration-time profiles for first-dose and steady-state piperacillin administered by intermittent or continuous dosing to critically ill patients with [SEPSIS] and (ii) to use population pharmacokinetics to perform Monte Carlo dosing simulations in order to assess the probability of target attainment (PTA) by minimum inhibitory concentration (MIC) for different [PIPERACILLIN] dosing regimens against bacterial pathogens commonly encountered in critical care units.","0"
"1962","TWrex-treat","[IRON DEFICIENCY ANEMIA]","49","71","[IRON]","33","37","In addition, three children with [IRON] refractory [IRON DEFICIENCY ANEMIA], and one sibling with iron responsive iron deficiency anemia were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1963","TWrex-treat","[IRON DEFICIENCY ANEMIA]","49","71","[IRON]","94","98","In addition, three children with iron refractory [IRON DEFICIENCY ANEMIA], and one sibling with [IRON] responsive iron deficiency anemia were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1964","TWrex-treat","[IRON DEFICIENCY ANEMIA]","49","71","[IRON]","110","114","In addition, three children with iron refractory [IRON DEFICIENCY ANEMIA], and one sibling with iron responsive [IRON] deficiency anemia were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1965","TWrex-treat","[IRON DEFICIENCY ANEMIA]","110","132","[IRON]","33","37","In addition, three children with [IRON] refractory iron deficiency anemia, and one sibling with iron responsive [IRON DEFICIENCY ANEMIA] were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1966","TWrex-treat","[IRON DEFICIENCY ANEMIA]","110","132","[IRON]","49","53","In addition, three children with iron refractory [IRON] deficiency anemia, and one sibling with iron responsive [IRON DEFICIENCY ANEMIA] were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1967","TWrex-treat","[IRON DEFICIENCY ANEMIA]","110","132","[IRON]","94","98","In addition, three children with iron refractory iron deficiency anemia, and one sibling with [IRON] responsive [IRON DEFICIENCY ANEMIA] were also examined for polymorphisms or sporadic mutations in TMPRSS6.","0"
"1968","TWrex-treat","[ENCEPHALITIS]","166","178","[ACYCLOVIR]","136","145","A 36-month-old boy who was presented with deterioration in speech and motor functions and fluctuation of consciousness was treated with [ACYCLOVIR] for 14 days for HSV [ENCEPHALITIS].","0"
"1969","TWrex-treat","[ASTHMA]","99","105","[THEOPHYLLINE]","49","61","The combination of low-dose inhaled steroid plus [THEOPHYLLINE] is a suitable treatment for moderate [ASTHMA].","0"
"1970","TWrex-treat","[HEPATITIS]","162","171","[RIBAVIRIN]","15","24","The effects of [RIBAVIRIN] and interferon (IFN) alpha have been investigated on cultured peripheral blood mononuclear cells, obtained from 15 patients with chronic [HEPATITIS] C virus (HCV) infection.","0"
"1971","TWrex-treat","[ADENOCARCINOMA]","242","256","[MITOMYCIN]","207","216","The urachal carcinoma, in a 64-year-old male with multiple lung metastases, had shown the resistance to several anti-neoplastic agents including cisplatinum, methotrexate, 5-FU, doxorubicin, epirubicin, and [MITOMYCIN] C. Because the tumor was [ADENOCARCINOMA] producing mucin and serum carcinoembryonic antigen (CEA) increased, which resembled colorectal carcinoma, we administrated Irinotecan, which was very effective as the CEA decreased from 98.3 to 38.7 ng/ml and the pulmonary metastatic lesions were reduced by 60%.","0"
"1972","TWrex-treat","[ARTERIAL HYPERTENSION]","33","54","[PRA]","66","69","Analysis of the various forms of [ARTERIAL HYPERTENSION] shows that [PRA] measurement has clinical value only: 1) in nephrovascular hypertension; 2) in primary hyper-reninism; 3) in primary hypercorticosuprarenalism; 4) to back up an indication for bilateral nephrectomy in terminal nephropathies with uncontrollable pressure value.","0"
"1974","TWrex-treat","[PAIN]","127","131","[PENTAZOCINE]","112","123","Analgesic action appeared approximately 15 min after the administration and lasted more than 90 min. Effects of [PENTAZOCINE] on [PAIN]-afferent pathways were studied and the evoked potential was recorded by tibial nerve stimulation.","0"
"1975","TWrex-treat","[ASPERGILLOSIS]","130","143","[AMPHOTERICIN]","26","38","The efficacy of nebulized [AMPHOTERICIN] B formulations was evaluated in persistently granulocytopenic rats with invasive pulmonary [ASPERGILLOSIS].","0"
"1977","TWrex-treat","[GASTRIC ULCER]","83","96","[CIMETIDINE]","0","10","[CIMETIDINE], an H2-receptor antagonist, may be indicated in foals diagnosed to have [GASTRIC ULCER]s; hepatic microsomal oxidative metabolism of drugs administered concurrently with cimetidine is decreased.","0"
"1979","TWrex-treat","[DISORDER]","106","114","[RISPERIDONE]","48","59","This report describes the outcome of adjunctive [RISPERIDONE] treatment in breakthrough episodes of bipolar [DISORDER].","0"
"1980","TWrex-treat","[NON INSULIN DEPENDENT DIABETES MELLITUS]","53","92","[INSULIN]","152","159","The aim of the study was to assess, in patients with [NON INSULIN DEPENDENT DIABETES MELLITUS] (NIDDM), either with previous failure to sulphonylureas or [INSULIN] treated since the disease started, if the combination of gliclazide to insulin therapy might induce a reduction of daily insulin requirement.","0"
"1981","TWrex-treat","[NON INSULIN DEPENDENT DIABETES MELLITUS]","53","92","[INSULIN]","231","238","The aim of the study was to assess, in patients with [NON INSULIN DEPENDENT DIABETES MELLITUS] (NIDDM), either with previous failure to sulphonylureas or insulin treated since the disease started, if the combination of gliclazide to [INSULIN] therapy might induce a reduction of daily insulin requirement.","0"
"1982","TWrex-treat","[NON INSULIN DEPENDENT DIABETES MELLITUS]","53","92","[INSULIN]","281","288","The aim of the study was to assess, in patients with [NON INSULIN DEPENDENT DIABETES MELLITUS] (NIDDM), either with previous failure to sulphonylureas or insulin treated since the disease started, if the combination of gliclazide to insulin therapy might induce a reduction of daily [INSULIN] requirement.","0"
"1983","TWrex-treat","[DIABETES]","99","107","[GLYBURIDE]","278","287","Parameters of insulin processing, including plasma PI and PI:IRI ratios, were determined in type 2 [DIABETES] patients enrolled in two randomized double-blind studies comparing the effects of rosiglitazone (4 or 8 mg/d) with placebo (study 1, 26-wk treatment) or the sulfonylurea [GLYBURIDE] (study 2, 52-wk treatment.","0"
"1984","TWrex-treat","[MYELOMA]","125","132","[INTERFERON]","0","10","[INTERFERON]s have both anti-proliferative and immune regulation effects, but the predominant mode of action of interferons in [MYELOMA] is still unclear.","0"
"1985","TWrex-treat","[MYELOMA]","125","132","[INTERFERON]","110","120","Interferons have both anti-proliferative and immune regulation effects, but the predominant mode of action of [INTERFERON]s in [MYELOMA] is still unclear.","0"
"1986","TWrex-treat","[DIABETES]","202","210","[INSULIN]","184","191","Amino acid 57 of DQ beta chains is of functional importance as it influences peptide binding, is part of B and T cell epitopes, and is associated with susceptibility and resistance to [INSULIN]-dependent [DIABETES] mellitus and humoral immunodeficiencies.","0"
"1987","TWrex-treat","[BLEEDING]","45","53","[APROTININ]","15","24","The benefit of [APROTININ] therapy in reducing [BLEEDING] is well known.","0"
"1988","TWrex-treat","[LUPUS]","25","30","[CYCLOSPORINE]","64","76","Twenty-one patients with [LUPUS] Nephritis (LN) were treated with [CYCLOSPORINE]-A (CsA) for three months.","0"
"1992","TWrex-treat","[PULMONARY EMBOLISM]","361","379","[HEPARIN]","37","44","We studied the course of F1+2, aPTT, [HEPARIN] doses administered and heparin concentrations, as well as prothrombin time, during the first 7 days of heparin therapy (target aPTT 70 s) and overlapping oral anticoagulation (target INR 2-3) in 26 patients routinely treated for deep venous thrombosis (deep venous thrombosis +/- pulmonary embolism, 23 patients) or [PULMONARY EMBOLISM] with a history of recurring deep venous thrombosis (3 patients.","0"
"1993","TWrex-treat","[PULMONARY EMBOLISM]","361","379","[HEPARIN]","68","75","We studied the course of F1+2, aPTT, heparin doses administered and [HEPARIN] concentrations, as well as prothrombin time, during the first 7 days of heparin therapy (target aPTT 70 s) and overlapping oral anticoagulation (target INR 2-3) in 26 patients routinely treated for deep venous thrombosis (deep venous thrombosis +/- pulmonary embolism, 23 patients) or [PULMONARY EMBOLISM] with a history of recurring deep venous thrombosis (3 patients.","0"
"1994","TWrex-treat","[PULMONARY EMBOLISM]","361","379","[HEPARIN]","148","155","We studied the course of F1+2, aPTT, heparin doses administered and heparin concentrations, as well as prothrombin time, during the first 7 days of [HEPARIN] therapy (target aPTT 70 s) and overlapping oral anticoagulation (target INR 2-3) in 26 patients routinely treated for deep venous thrombosis (deep venous thrombosis +/- pulmonary embolism, 23 patients) or [PULMONARY EMBOLISM] with a history of recurring deep venous thrombosis (3 patients.","0"
"1995","TWrex-treat","[CANDIDOSIS]","70","80","[FLUCONAZOLE]","107","118","In this report, we describe a patient with recurrent episodes of oral [CANDIDOSIS] who finally suffered from [FLUCONAZOLE]-refractory oral and oesophageal candidosis.","0"
"1996","TWrex-treat","[CANDIDOSIS]","151","161","[FLUCONAZOLE]","107","118","In this report, we describe a patient with recurrent episodes of oral candidosis who finally suffered from [FLUCONAZOLE]-refractory oral and oesophageal [CANDIDOSIS].","0"
"1997","TWrex-treat","[LEUKEMIA]","59","67","[METHOTREXATE]","174","186","We report a patient treated for small lymphocytic lymphoma/[LEUKEMIA] with cerebral venous and sinus thrombosis (CVST) after lumbar puncture with intrathecal administration of [METHOTREXATE] (MTX.","0"
"1998","TWrex-treat","[CYSTINOSIS]","130","140","[CYSTEAMINE]","86","96","Pantethine is an experimental hypolipemic agent and has been suggested as a source of [CYSTEAMINE] in the treatment of nephropathic [CYSTINOSIS].","0"
"1999","TWrex-treat","[NE]","116","118","[O2]","77","79","We conclude that Epi in high doses or after propranolol depresses intestinal [O2] extraction by the same mechanism as [NE] and SS, but the mechanism through which Epi increases intestinal o2 extraction is unclear.","0"
"2000","TWrex-treat","[NE]","116","118","[O2]","184","186","We conclude that Epi in high doses or after propranolol depresses intestinal o2 extraction by the same mechanism as [NE] and SS, but the mechanism through which Epi increases intestinal [O2] extraction is unclear.","0"
"2001","TWrex-treat","[INFERTILITY]","5","16","[BROMOCRIPTINE]","58","71","When [INFERTILITY] is the primary indication for treatment, [BROMOCRIPTINE] use has an extensive safety experience and is preferred by some clinicians.","0"
"2002","TWrex-treat","[HG]","371","373","[INSULIN]","46","53","To study conditions involved in inhibition of [INSULIN] secretion, we compared changes in plasma insulin concentration in response to acute increases in glucose and arginine concentrations in a group of normal, late gestation fetal sheep (euglycemic controls, EC) and a comparable group made chronically hyperglycemic by constant maternal glucose infusion (hyperglycemics, [HG].","0"
"2003","TWrex-treat","[HG]","371","373","[INSULIN]","95","102","To study conditions involved in inhibition of insulin secretion, we compared changes in plasma [INSULIN] concentration in response to acute increases in glucose and arginine concentrations in a group of normal, late gestation fetal sheep (euglycemic controls, EC) and a comparable group made chronically hyperglycemic by constant maternal glucose infusion (hyperglycemics, [HG].","0"
"2004","TWrex-treat","[SCHISTOSOMIASIS]","147","162","[PRAZIQUANTEL]","221","233","Peripheral blood T cell phenotypes, CD3-induced mitogenesis and soluble IL 2 receptor and CD8 in sera were studied in intestinal and hepatosplenic [SCHISTOSOMIASIS] mansoni before and three to six months after therapy with [PRAZIQUANTEL].","0"
"2005","TWrex-treat","[ESOPHAGITIS]","80","91","[SUCRALFATE]","17","27","We conclude that [SUCRALFATE] monotherapy in patients with milder forms of reflux [ESOPHAGITIS] is comparable with a combination of sucralfate during the day and ranitidine after dinnertime.","0"
"2006","TWrex-treat","[ESOPHAGITIS]","80","91","[SUCRALFATE]","128","138","We conclude that sucralfate monotherapy in patients with milder forms of reflux [ESOPHAGITIS] is comparable with a combination of [SUCRALFATE] during the day and ranitidine after dinnertime.","0"
"2007","TWrex-treat","[HEMOPHILIA]","192","202","[FACTOR VIII]","13","24","The ratio of [FACTOR VIII] coagulant activity (VIIIC) or antigen (VIIICAg) to that of factor VIII related antigen (VIIIRAg) was measured in 15 normals, 21 obligatory and 23 possible carriers of [HEMOPHILIA].","0"
"2008","TWrex-treat","[HEMOPHILIA]","192","202","[FACTOR VIII]","84","95","The ratio of factor VIII coagulant activity (VIIIC) or antigen (VIIICAg) to that of [FACTOR VIII] related antigen (VIIIRAg) was measured in 15 normals, 21 obligatory and 23 possible carriers of [HEMOPHILIA].","0"
"2009","TWrex-treat","[PNEUMONIA]","166","175","[ISETHIONATE]","12","23","Pentamidine [ISETHIONATE], discovered to have antiprotozoal activity in 1938, has recently been approved in the United States for the treatment of Pneumocystis carinii [PNEUMONIA].","0"
"2010","TWrex-treat","[CRYPTOSPORIDIOSIS]","62","79","[PAROMOMYCIN]","23","34","To test the effects of [PAROMOMYCIN], 10 patients with AIDS and [CRYPTOSPORIDIOSIS] were randomized to paromomycin or placebo in a double-blind trial.","0"
"2011","TWrex-treat","[CRYPTOSPORIDIOSIS]","62","79","[PAROMOMYCIN]","99","110","To test the effects of paromomycin, 10 patients with AIDS and [CRYPTOSPORIDIOSIS] were randomized to [PAROMOMYCIN] or placebo in a double-blind trial.","0"
"2012","TWrex-treat","[SCLC]","36","40","[TOPOTECAN]","94","103","In addition to its potential use in [SCLC] and Nsclc, the feasibility and antitumor activity of [TOPOTECAN] as single-agent therapy and in combination therapy are under active investigation in a variety of other solid and hematologic tumors.","0"
"2013","TWrex-treat","[SCLC]","46","50","[TOPOTECAN]","94","103","In addition to its potential use in sclc and N[SCLC], the feasibility and antitumor activity of [TOPOTECAN] as single-agent therapy and in combination therapy are under active investigation in a variety of other solid and hematologic tumors.","0"
"2014","TWrex-treat","[POSTMENOPAUSAL OSTEOPOROSIS]","15","42","[RALOXIFENE HYDROCHLORIDE]","138","162","For women with [POSTMENOPAUSAL OSTEOPOROSIS], therapy with hormone replacement, bisphosphonates (alendronate sodium or risedronate sodium), [RALOXIFENE HYDROCHLORIDE], or calcitonin should be considered.","0"
"2015","TWrex-treat","[INFECTION]","161","170","[GENTAMICIN]","24","34","Only the combination of [GENTAMICIN] plus either ceftriaxone or aztreonam appeared to be highly active under conditions simulating serious septicemias and urinary [INFECTION]s caused by Psudomonas aeruginosa.","0"
"2016","TWrex-treat","[ANAEMIA]","56","63","[IRON]","40","44","Sixty three patients were found to have [IRON] deficiency [ANAEMIA] and were treated with iron (6 mg/kg/day) for three months.","0"
"2017","TWrex-treat","[ANAEMIA]","56","63","[IRON]","86","90","Sixty three patients were found to have iron deficiency [ANAEMIA] and were treated with [IRON] (6 mg/kg/day) for three months.","0"
"2018","TWrex-treat","[EPILEPSY]","131","139","[DRUG]","206","210","We performed an open, double-blind, and long-term study of vigabatrin (gamma-vinyl-GABA, GVG) in patients with treatment-resistant [EPILEPSY] who were receiving only one or at most two standard antiepileptic [DRUG]s (AEDs.","0"
"2019","TWrex-treat","[AID]","68","71","[+ DDC]","91","96","In combination drug therapy, TMB postulates the following for HIV : [AID]S: At(1+) + AZT(3+) [+ DDC](1+) > AZT(3+) + ddc(1+) = AZT(3+) + At(1+) > AZT(3+) > At(1+) + ddc(1+) > ddc(1+) = At(1+.","0"
"2020","TWrex-treat","[AID]","68","71","[+ DDC]","111","116","In combination drug therapy, TMB postulates the following for HIV : [AID]S: At(1+) + AZT(3+) + ddc(1+) > AZT(3+) [+ DDC](1+) = AZT(3+) + At(1+) > AZT(3+) > At(1+) + ddc(1+) > ddc(1+) = At(1+.","0"
"2021","TWrex-treat","[AID]","68","71","[+ DDC]","159","164","In combination drug therapy, TMB postulates the following for HIV : [AID]S: At(1+) + AZT(3+) + ddc(1+) > AZT(3+) + ddc(1+) = AZT(3+) + At(1+) > AZT(3+) > At(1+) [+ DDC](1+) > ddc(1+) = At(1+.","0"
"2022","TWrex-treat","[ENDOCARDITIS]","25","37","[VANCOMYCIN]","121","131","A patient with infective [ENDOCARDITIS] (IE) caused by methicillin-resistant Staphylococcus aureus (MRSA) was treated with [VANCOMYCIN] (VAN.","0"
"2023","TWrex-treat","[ILLNESS]","78","85","[LITHIUM]","128","135","15 patients with formerly endogenous recurrent depression or manic-depressive [ILLNESS] free of psychotic symptoms, who are under [LITHIUM] prophylaxis about 3,9 years, and 16 healthy controls with approximately the same age and sex were tested with 0,1 U Insulin/kg, 200 micrograms TRH and 50 micrograms LHRH for their hGH-, TSH-, hPRL-, FSH-, LH-and Cortisol levels about 2 hours.","0"
"2024","TWrex-treat","[PROSTATITIS]","104","115","[CIPROFLOXACIN]","65","78","We describe a 30-year-old man who was given a 15-day course with [CIPROFLOXACIN] 500 mg twice a day for a [PROSTATITIS].","0"
"2025","TWrex-treat","[CHRONIC HEPATITIS C]","25","44","[INTERFERON]","70","80","Sixty-nine patients with [CHRONIC HEPATITIS C] (CH-C) were treated with [INTERFERON] therapy, and serum collagen type IV (s-collagen IV) levels were measured by enzyme immunoassay to analyze the responsiveness to interferon therapy.","0"
"2026","TWrex-treat","[CHRONIC HEPATITIS C]","25","44","[INTERFERON]","209","219","Sixty-nine patients with [CHRONIC HEPATITIS C] (CH-C) were treated with interferon therapy, and serum collagen type IV (s-collagen IV) levels were measured by enzyme immunoassay to analyze the responsiveness to [INTERFERON] therapy.","0"
"2027","TWrex-treat","[ASTHMA]","31","37","[BECLOMETHASONE DIPROPIONATE]","47","74","A glucocorticosteroid used for [ASTHMA] therapy, [BECLOMETHASONE DIPROPIONATE], was selected as an experimental model drug.","0"
"2028","TWrex-treat","[ARTERIAL HYPERTENSION]","77","98","[LISINOPRIL]","50","60","A case of fulminant hepatitis in a patient taking [LISINOPRIL] for 5 weeks for [ARTERIAL HYPERTENSION] is reported.","0"
"2029","TWrex-treat","[HYPERTENSION]","27","39","[TIMOLOL]","56","63","In 25 patients with ocular [HYPERTENSION] and open angles [TIMOLOL] maleate lowered the intraocular pressure (IOP) of 71% of the 49 eyes treated, keeping it below 22 mm Hg during 4 years of therapy.","0"
"2030","TWrex-treat","[HCMV]","44","48","[GANCICLOVIR]","75","86","The antiviral activity of ISIS 2922 against [HCMV] was additive with that of [GANCICLOVIR] (9-(1,3-dihydroxy-2-propoxymethylguanine); DHPG) or foscarnet (phosphonoformate.","0"
"2032","TWrex-treat","[DIABETES]","138","146","[INSULIN]","120","127","Combined pancreas-kidney transplantation is nowadays the treatment of choice in carefully selected patients with type 1 [INSULIN]-dependent [DIABETES] mellitus and end-stage renal failure.","0"
"2033","TWrex-treat","[DISORDER]","58","66","[LITHIUM]","89","96","The authors examined a sample of 17 patients with bipolar [DISORDER] who were treated with [LITHIUM] during a depressive episode and who required paroxetine as an adjunctive antidepressant to ongoing lithium treatment.","0"
"2034","TWrex-treat","[DISORDER]","58","66","[LITHIUM]","196","203","The authors examined a sample of 17 patients with bipolar [DISORDER] who were treated with lithium during a depressive episode and who required paroxetine as an adjunctive antidepressant to ongoing [LITHIUM] treatment.","0"
"2035","TWrex-treat","[OSTEOPOROSIS]","141","153","[VITAMIN D]","108","117","Together, these results provide a rationale for the clinical utility of alfacalcidol and its advantage over [VITAMIN D](3) in the treatment of [OSTEOPOROSIS].","0"
"2036","TWrex-treat","[SPONDYLITIS]","255","266","[PIROXICAM]","55","64","It has proved as effective as diclofenac, naproxen and [PIROXICAM] in patients with osteoarthritis, diclofenac, ketorolac, tenoxicam and indomethacin in patients with rheumatoid arthritis and tenoxicam, naproxen and indomethacin in patients with ankylosing [SPONDYLITIS].","0"
"2037","TWrex-treat","[CIRRHOSIS]","51","60","[FRUSEMIDE]","209","218","Nineteen patients with severe oedema due to either [CIRRHOSIS] of the liver or to congestive cardiac failure, who had failed to respond to previous diuretic therapy, were treated with either increasing doses of [FRUSEMIDE] (Group A), or with frusemide in a fixed dose of 80 mg daily and increasing doses of spironolactone (Group B.","0"
"2038","TWrex-treat","[CIRRHOSIS]","51","60","[FRUSEMIDE]","238","247","Nineteen patients with severe oedema due to either [CIRRHOSIS] of the liver or to congestive cardiac failure, who had failed to respond to previous diuretic therapy, were treated with either increasing doses of frusemide (Group A), or with [FRUSEMIDE] in a fixed dose of 80 mg daily and increasing doses of spironolactone (Group B.","0"
"2039","TWrex-treat","[TYPE 2 DIABETES]","266","281","[INSULIN]","44","51","In this review, we discuss the link between [INSULIN] resistance and endothelial cell function in humans and demonstrate the complimentary information provided by murine models of obesity and insulin resistance in our understanding of the vasculopathy associated with [TYPE 2 DIABETES] and obesity.","0"
"2040","TWrex-treat","[TYPE 2 DIABETES]","266","281","[INSULIN]","190","197","In this review, we discuss the link between insulin resistance and endothelial cell function in humans and demonstrate the complimentary information provided by murine models of obesity and [INSULIN] resistance in our understanding of the vasculopathy associated with [TYPE 2 DIABETES] and obesity.","0"
"2041","TWrex-treat","[PARKINSON'S DISEASE]","40","59","[LEVODOPA]","91","99","SPD also relieves the motor symptoms of [PARKINSON'S DISEASE] (PD) when co-administered with [LEVODOPA].","0"
"2042","TWrex-treat","[THROMBOSIS]","58","68","[STREPTOKINASE]","106","119","The prospective study included 15 patients with deep vein [THROMBOSIS]: 5 were treated in the hospital with [STREPTOKINASE] and heparin and 5 only with heparin, 5 were treated at home with only phenprocoumon.","0"
"2043","TWrex-treat","[FSGS]","89","93","[CYA]","16","19","We believe that [CYA] and native nephrectomy may limit or reverse progression of recurrent [FSGS] in renal allografts of Japanese pediatric patients, although this is a limited study.","0"
"2044","TWrex-treat","[OVARIAN TUMOUR]","116","130","[CISPLATIN]","81","90","The evaluation of the cytotoxic activity of compounds 6b and 6d against pairs of [CISPLATIN]-sensitive and -resistant [OVARIAN TUMOUR] cells shows that both compounds may be endowed with interesting antitumour properties because they are able to circumvent cisplatin resistance in A2780cisR, CH1cisR and Pam 212-ras tumour cells.","0"
"2045","TWrex-treat","[OVARIAN TUMOUR]","116","130","[CISPLATIN]","253","262","The evaluation of the cytotoxic activity of compounds 6b and 6d against pairs of cisplatin-sensitive and -resistant [OVARIAN TUMOUR] cells shows that both compounds may be endowed with interesting antitumour properties because they are able to circumvent [CISPLATIN] resistance in A2780cisR, CH1cisR and Pam 212-ras tumour cells.","0"
"2046","TWrex-treat","[INFARCTION]","88","98","[METOPROLOL]","133","143","Fourteen patients, admitted within 12 hours from the clinical onset of acute myocardial [INFARCTION], were initially given intravenous [METOPROLOL] (5 + 5 + 5 mg) followed 15 minutes later by an additional 50 mg oral dose.","0"
"2047","TWrex-treat","[LEUKEMIA]","50","58","[TRIOXIDE]","74","82","Although clearly effective in acute promyelocytic [LEUKEMIA] (APL), arsenic [TRIOXIDE] (ATO) demonstrates little clinical benefit as a single agent in the treatment of non-APL hematological malignancies.","0"
"2048","TWrex-treat","[XEROSTOMIA]","224","234","[PILOCARPINE]","132","143","These data support that the beta-adrenergic side effect triggering the periodical synthesis of export proteins during the course of [PILOCARPINE] treatment accounts for the selative efficiency of pilocarpine in the therapy of [XEROSTOMIA].","0"
"2049","TWrex-treat","[XEROSTOMIA]","224","234","[PILOCARPINE]","194","205","These data support that the beta-adrenergic side effect triggering the periodical synthesis of export proteins during the course of pilocarpine treatment accounts for the selative efficiency of [PILOCARPINE] in the therapy of [XEROSTOMIA].","0"
"2050","TWrex-treat","[MELANOMA]","10","18","[IFN]","137","140","Malignant [MELANOMA] tumors obtained from 17 patients exhibited dose-dependent activation of STAT1 and STAT2 in response to treatment with [IFN]-alpha.","0"
"2051","TWrex-treat","[PALSY]","98","103","[BACLOFEN]","42","50","We report on an ambulatory patient with a [BACLOFEN] pump for control of spasticity due to cerebral [PALSY] and dystonia; the patient suffered repeated episodes of catheter migration.","0"
"2052","TWrex-treat","[MYXEDEMA]","77","85","[T4]","159","161","After treatment for 22 weeks, the patient, with typical clinical features of [MYXEDEMA], was referred to our outpatient clinic with undetectable serum levels of [T4].","0"
"2054","TWrex-treat","[MEDIA]","208","213","[CEFIXIME]","61","69","Amoxicillin clavulante given twice daily rather then thrice, [CEFIXIME] given once a day, and a single intramuscular dose of ceftriaxone have all shown acceptable--though not exceptional--cure rates for otitis [MEDIA].","0"
"2055","TWrex-treat","[HYPERTENSION]","234","246","[VERAPAMIL]","77","86","The antihypertensive effects of the regular immediate release formulation of [VERAPAMIL] (verapamil IR) and the newer sustained release formulation of verapamil (verapamil SR) were compared in Hispanic patients with untreated essential [HYPERTENSION].","0"
"2057","TWrex-treat","[HYPERTENSION]","234","246","[VERAPAMIL]","149","158","The antihypertensive effects of the regular immediate release formulation of verapamil (verapamil IR) and the newer sustained release formulation of [VERAPAMIL] (verapamil SR) were compared in Hispanic patients with untreated essential [HYPERTENSION].","0"
"2059","TWrex-treat","[ANAEMIA]","73","80","[EPO]","35","38","The use of SCF in combination with [EPO] in the prevention or treatment of [ANAEMIA] in premature infants warrants further investigation.","0"
"2060","TWrex-treat","[HYPERTENSION]","146","158","[TIMOLOL]","67","74","That study compared dorzolamide 2% TID with betaxolol 0.5% BID and [TIMOLOL] 0.5% BID as monotherapy in patients with open-angle glaucoma or ocular [HYPERTENSION].","0"
"2061","TWrex-treat","[SCHIZOPHRENIA]","146","159","[DECANOATE]","43","52","A 1 year double-blind trial of bromperidol [DECANOATE] and fluphenazine decanoate was conducted in the maintenance treatment of 47 outpatients with [SCHIZOPHRENIA].","0"
"2062","TWrex-treat","[SCHIZOPHRENIA]","146","159","[DECANOATE]","70","79","A 1 year double-blind trial of bromperidol decanoate and fluphenazine [DECANOATE] was conducted in the maintenance treatment of 47 outpatients with [SCHIZOPHRENIA].","0"
"2063","TWrex-treat","[THROMBOSIS]","260","270","[HEPARIN]","153","160","We conducted a prospective, randomized trial to compare the effectiveness of a regimen of antithrombin III, given intravenously once daily, and low-dose [HEPARIN] with a regimen of dextran 40, given intravenously, in preventing venographically documented venous [THROMBOSIS] after total hip arthroplasty.","0"
"2064","TWrex-treat","[FALCIPARUM MALARIA]","126","144","[CHLOROQUINE]","274","285","At a time when Fansimef, the fixed combination of mefloquine, sulfadoxine and pyrimethamine was considered for prophylaxis of [FALCIPARUM MALARIA], a randomized double-blind study comparing the efficacy and tolerability of Fansimef with that of Lariam (mefloquine), Fansidar, [CHLOROQUINE] and placebo in malaria prophylaxis was performed in Thailand from July 1987 to January 1988.","0"
"2065","TWrex-treat","[THROMBOEMBOLIC EVENT]","119","139","[WARFARIN]","76","84","This study evaluated enoxaparin alone versus initial enoxaparin followed by [WARFARIN] in secondary prevention of venous [THROMBOEMBOLIC EVENT]s in adults with active malignancy.","0"
"2066","TWrex-treat","[MELANOMA]","121","129","[INTERFERON]","95","105","On the basis of the SRCA screening we developed a four-drug chemotherapy regimen combined with [INTERFERON] for metastatic [MELANOMA].","0"
"2067","TWrex-treat","[VOMITING]","239","247","[APREPITANT]","203","213","The objective of this multicenter, phase II, open-label study was to evaluate the safety and efficacy of the newest 5-hydroxytryptamine3 (5-HT3) receptor antagonist, palonosetron, plus dexamethasone and [APREPITANT] in preventing nausea and [VOMITING] in patients receiving moderately emetogenic chemotherapy.","0"
"2068","TWrex-treat","[SEIZURE]","208","215","[ACETAZOLAMIDE]","394","407","The relationships between inhibition of carbonic anhydrase (CA) activity in cytoplasmic, microsomal, and myelin subcellular fractions obtained from cerebral cortex, subcortex, and cerebellum and electroshock [SEIZURE] threshold (EST) and modification of the extension/flexion (E/F) ratio following maximal electroshock seizures (MES) were ascertained in Swiss-Webster mice given 40 and 200 mg/kg [ACETAZOLAMIDE].","0"
"2069","TWrex-treat","[SEIZURE]","317","324","[ACETAZOLAMIDE]","394","407","The relationships between inhibition of carbonic anhydrase (CA) activity in cytoplasmic, microsomal, and myelin subcellular fractions obtained from cerebral cortex, subcortex, and cerebellum and electroshock seizure threshold (EST) and modification of the extension/flexion (E/F) ratio following maximal electroshock [SEIZURE]s (MES) were ascertained in Swiss-Webster mice given 40 and 200 mg/kg [ACETAZOLAMIDE].","0"
"2070","TWrex-treat","[VASOMOTOR RHINITIS]","90","108","[IPRATROPIUM BROMIDE]","14","33","Topical nasal [IPRATROPIUM BROMIDE] is highly effective in the control of the rhinorrhea of [VASOMOTOR RHINITIS].","0"
"2071","TWrex-treat","[EPILEPSY]","79","87","[ANTIEPILEPTIC DRUG]","162","180","Behavioural disturbances and psychotic reactions are commoner in patients with [EPILEPSY] than in the general population and may be precipitated by the majority of [ANTIEPILEPTIC DRUG]s, including the newer ones.","0"
"2072","TWrex-treat","[ULCER]","127","132","[RANITIDINE]","79","89","In conclusion, 20 mg omeprazole administered once daily was superior to 300 mg [RANITIDINE] administered once daily for duodenal [ULCER] healing and symptom relief.","0"
"2073","TWrex-treat","[DEPRESSION]","109","119","[PHENELZINE]","0","10","[PHENELZINE] sulfate, 60 mg daily, was significantly more effective than placebo in relieving symptoms of both [DEPRESSION] and anxiety.","0"
"2074","TWrex-treat","[APL]","0","3","[RETINOIC ACID]","40","53","[APL] patients are initially treated with [RETINOIC ACID], but most develop resistance and relapse.","0"
"2075","TWrex-treat","[ARTERIAL HYPERTENSION]","142","163","[NADOLOL]","24","31","The pharmacokinetics of [NADOLOL] in blood serum and its excretion in the urine were studied in 6 male patients (aged from 35 to 59 years) with [ARTERIAL HYPERTENSION] for 48 h and, respectively, 72 h after a single per os administration of nadolol in a dose of 80 mg in the morning (9.00 a.m.), in daytime (15.00 p.m.) and in the evening (20.00 p.m.","0"
"2076","TWrex-treat","[ARTERIAL HYPERTENSION]","142","163","[NADOLOL]","237","244","The pharmacokinetics of nadolol in blood serum and its excretion in the urine were studied in 6 male patients (aged from 35 to 59 years) with [ARTERIAL HYPERTENSION] for 48 h and, respectively, 72 h after a single per os administration of [NADOLOL] in a dose of 80 mg in the morning (9.00 a.m.), in daytime (15.00 p.m.) and in the evening (20.00 p.m.","0"
"2077","TWrex-treat","[VENTRICULAR FIBRILLATION]","97","121","[AMIODARONE]","58","68","We evaluated the effect of two different doses of desethyl[AMIODARONE] (DEA) and amiodarone on the [VENTRICULAR FIBRILLATION] threshold (VFT.","0"
"2078","TWrex-treat","[VENTRICULAR FIBRILLATION]","97","121","[AMIODARONE]","79","89","We evaluated the effect of two different doses of desethylamiodarone (DEA) and [AMIODARONE] on the [VENTRICULAR FIBRILLATION] threshold (VFT.","0"
"2079","TWrex-treat","[ATRIAL FIBRILLATION]","155","174","[WARFARIN]","84","92","One of the important recent advances in stroke prevention is the demonstration that [WARFARIN] can substantially reduce the risk for stroke in patients with [ATRIAL FIBRILLATION] (AF.","0"
"2080","TWrex-treat","[CEREBRAL ISCHEMIA]","83","100","[ASPIRIN]","66","73","The objective of the present study was to evaluate the effects of [ASPIRIN] on focal [CEREBRAL ISCHEMIA] in diabetic rats.","0"
"2081","TWrex-treat","[ITP]","109","112","[ATP]","136","139","The relative order of nucleotide binding by Gh is GTP gamma S greater than GTP greater than GDP greater than [ITP] much much greater than [ATP] greater than or equal to adenyl-5'-yl imidodiphosphate, which is similar to that observed for other heterotrimeric G-proteins involved in receptor signaling.","0"
"2082","TWrex-treat","[MINOR EPILEPSY]","49","63","[ETHOSUXIMIDE]","0","12","[ETHOSUXIMIDE] is one of the means of treatment of [MINOR EPILEPSY] but hardly any data on its mechanism of action are available in the literature.","0"
"2084","TWrex-treat","[PAIN]","51","55","[BUPIVACAINE]","187","198","The estimated treatment difference for duration of [PAIN] relief was -4 (90% CI -13, 6) min. Thirty patients failed to achieve pain relief after the first injection (20 patients after S(-)-[BUPIVACAINE] and 10 after RS-bupivacaine; P = 0.039.","0"
"2085","TWrex-treat","[PAIN]","51","55","[BUPIVACAINE]","215","226","The estimated treatment difference for duration of [PAIN] relief was -4 (90% CI -13, 6) min. Thirty patients failed to achieve pain relief after the first injection (20 patients after S(-)-bupivacaine and 10 after RS-[BUPIVACAINE]; P = 0.039.","0"
"2086","TWrex-treat","[PAIN]","125","129","[BUPIVACAINE]","187","198","The estimated treatment difference for duration of pain relief was -4 (90% CI -13, 6) min. Thirty patients failed to achieve [PAIN] relief after the first injection (20 patients after S(-)-[BUPIVACAINE] and 10 after RS-bupivacaine; P = 0.039.","0"
"2087","TWrex-treat","[PAIN]","125","129","[BUPIVACAINE]","215","226","The estimated treatment difference for duration of pain relief was -4 (90% CI -13, 6) min. Thirty patients failed to achieve [PAIN] relief after the first injection (20 patients after S(-)-bupivacaine and 10 after RS-[BUPIVACAINE]; P = 0.039.","0"
"2088","TWrex-treat","[AD]","136","138","[GALANTAMINE]","87","98","Attention has, therefore, recently turned to the use of cholinergic treatments such as [GALANTAMINE] (Reminyl), which has demonstrated bro[AD]-spectrum and long-term efficacy in AD, for the treatment of patients with VaD or AD with CVD.","0"
"2089","TWrex-treat","[AD]","174","176","[GALANTAMINE]","87","98","Attention has, therefore, recently turned to the use of cholinergic treatments such as [GALANTAMINE] (Reminyl), which has demonstrated broad-spectrum and long-term efficacy in [AD], for the treatment of patients with VaD or AD with CVD.","0"
"2090","TWrex-treat","[AD]","214","216","[GALANTAMINE]","87","98","Attention has, therefore, recently turned to the use of cholinergic treatments such as [GALANTAMINE] (Reminyl), which has demonstrated broad-spectrum and long-term efficacy in AD, for the treatment of patients with V[AD] or AD with CVD.","0"
"2091","TWrex-treat","[AD]","220","222","[GALANTAMINE]","87","98","Attention has, therefore, recently turned to the use of cholinergic treatments such as [GALANTAMINE] (Reminyl), which has demonstrated broad-spectrum and long-term efficacy in AD, for the treatment of patients with VaD or [AD] with CVD.","0"
"2092","TWrex-treat","[CARCINOMA]","120","129","[BLEOMYCIN]","53","62","A phase III 2 X 2 factorial trial of cisplatinum and [BLEOMYCIN] in 116 patients with recurrent or advanced squamous cell [CARCINOMA] of the head and neck is reported.","0"
"2093","TWrex-treat","[PAIN]","238","242","[IBUPROFEN]","163","172","The purpose of this single-dose, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study was to compare MK-0703 12.5, 50, and 100 mg with [IBUPROFEN] 400 mg or placebo in patients who experienced moderate to severe [PAIN] after surgical removal of at least 2 third molars.","0"
"2094","TWrex-treat","[PARKINSON'S DISEASE]","46","65","[BROMOCRIPTINE]","15","28","The effects of [BROMOCRIPTINE] in patients with [PARKINSON'S DISEASE] manifesting various problems in levodopa therapy were tested in a double-blind manner with the collaboration of 59 institutions.","0"
"2096","TWrex-treat","[CYSTIC FIBROSIS]","57","72","[AMILORIDE]","128","137","In an attempt to produce an animal model for the disease [CYSTIC FIBROSIS] (CF), mice were treated chronically with the diuretics [AMILORIDE] and furosemide, in order to cause chronic inhibition of transepithelial ion transport.","0"
"2097","TWrex-treat","[OVERDOSE]","69","77","[CHARCOAL]","123","131","A comprehensive review of reported studies in volunteer subjects and [OVERDOSE] patients showed that repeated dose activated [CHARCOAL] markedly decreased the half-life and/or increased the clearance of a wide range of drugs.","0"
"2098","TWrex-treat","[PULMONARY EMBOLISM]","230","248","[UFH]","133","136","A meta-analyses of randomised trials showed a significant decrease in deep venous thrombosis in women receiving unfractioned heparin [UFH] compared with controls, and revealed no significant difference in deep venous thrombosis and [PULMONARY EMBOLISM] between patients who received ufh and those who received low-molecular weight heparin LMWH.","0"
"2099","TWrex-treat","[PULMONARY EMBOLISM]","230","248","[UFH]","279","282","A meta-analyses of randomised trials showed a significant decrease in deep venous thrombosis in women receiving unfractioned heparin ufh compared with controls, and revealed no significant difference in deep venous thrombosis and [PULMONARY EMBOLISM] between patients who received [UFH] and those who received low-molecular weight heparin LMWH.","0"
"2101","TWrex-treat","[HEMOPHILIA]","127","137","[FVIII]","45","50","Factor VIII coagulant antigen (fviii:Ag) and [FVIII] coagulant activity (fviii:C) were measured in 102 healthy individuals, in 5 [HEMOPHILIA] A carriers and in 21 hemophilia A patients before and after infusion of heat-treated high-purity fviii concentrates.","0"
"2103","TWrex-treat","[HEMOPHILIA]","127","137","[FVIII]","235","240","Factor VIII coagulant antigen (fviii:Ag) and fviii coagulant activity (fviii:C) were measured in 102 healthy individuals, in 5 [HEMOPHILIA] A carriers and in 21 hemophilia A patients before and after infusion of heat-treated high-purity [FVIII] concentrates.","0"
"2105","TWrex-treat","[HEMOPHILIA]","159","169","[FVIII]","45","50","Factor VIII coagulant antigen (fviii:Ag) and [FVIII] coagulant activity (fviii:C) were measured in 102 healthy individuals, in 5 hemophilia A carriers and in 21 [HEMOPHILIA] A patients before and after infusion of heat-treated high-purity fviii concentrates.","0"
"2107","TWrex-treat","[HEMOPHILIA]","159","169","[FVIII]","235","240","Factor VIII coagulant antigen (fviii:Ag) and fviii coagulant activity (fviii:C) were measured in 102 healthy individuals, in 5 hemophilia A carriers and in 21 [HEMOPHILIA] A patients before and after infusion of heat-treated high-purity [FVIII] concentrates.","0"
"2108","TWrex-treat","[VOMITING]","143","151","[SCOPOLAMINE]","57","68","Compared with flights using placebo, flights with buccal [SCOPOLAMINE] resulted in significantly lower scores for nausea (31%-35% reduction) and [VOMITING] (50% reduction in number of parabolas with vomiting.","0"
"2109","TWrex-treat","[VOMITING]","195","203","[SCOPOLAMINE]","57","68","Compared with flights using placebo, flights with buccal [SCOPOLAMINE] resulted in significantly lower scores for nausea (31%-35% reduction) and vomiting (50% reduction in number of parabolas with [VOMITING].","0"
"2110","TWrex-treat","[VON WILLEBRAND]","31","45","[FACTOR VIII]","0","11","[FACTOR VIII] activity (VIII:C), [VON WILLEBRAND] factor antigen (vWF:Ag), tissue plasminogen activator antigen (tPA), plasminogen activator inhibitor activity (PAI-1), antithrombin III, protein C and protein S were assayed before and 1, 3, 6, 12, 18, and 24 months after BMT.","0"
"2111","TWrex-treat","[INFLAMMATION]","48","60","[DICLOFENAC]","174","184","Piroxicam exercised a significant action on the [INFLAMMATION]-specific parameters (reduction of BSR by 6.15 mm maximum and of the alpha 2-globulin fraction by 0.75%), whereas [DICLOFENAC] did not.","0"
"2114","TWrex-treat","[MELANOMA]","95","103","[INTERFERON]","64","74","These data indicate a pathogenetic significance of disorders in [INTERFERON] production in uveal [MELANOMA] and may be used for the disease prognosis.","0"
"2115","TWrex-treat","[SEPSIS]","98","104","[ALPHA]","12","17","Drotrecogin [ALPHA] (activated), when administered to adult patients with clinically defined severe [SEPSIS], demonstrated a 6.1% absolute reduction (p=0.005) in 28-day all-cause mortality in one published, randomized, double-blind study of 1,690 patients (PROWESS.","0"
"2120","TWrex-treat","[ANOREXIA]","112","120","[TETRAHYDROCANNABINOL]","68","88","Purpose: To evaluate the appetite-stimulating properties of delta-9-[TETRAHYDROCANNABINOL] (THC) in patients with [ANOREXIA] due to advanced cancer.","0"
"2121","TWrex-treat","[DYSRHYTHMIA]","215","226","[ANTIARRHYTHMIC AGENT]","139","159","Three patients are free of relapses without antiarrhythmic drugs (follow-up: 14 to 17 months); three others are also free of relapses, but [ANTIARRHYTHMIC AGENT]s were required for treatment of other supraventricular [DYSRHYTHMIA]s (follow-up: 3 to 17 months); atrial flutter recurred within several days and persisted in spite of two more procedures in two patients.","0"
"2123","TWrex-treat","[CLUSTER HEADACHE]","74","90","[SUMATRIPTAN]","35","46","Recent data have demonstrated that [SUMATRIPTAN] offers effective relief of [CLUSTER HEADACHE] attacks, a condition where suffers experience repeated severe headache attacks, of short duration, during a cluster period.","0"
"2124","TWrex-treat","[TETANUS]","105","112","[TETANUS TOXOID]","8","22","Because [TETANUS TOXOID] is relatively heat stable, the traditional birth attendants were able to keep the [TETANUS] toxoid-filled UniJect devices in their homes for up to one month without refrigeration.","0"
"2125","TWrex-treat","[HYPERCALCAEMIA]","12","26","[APD]","64","67","Symptoms of [HYPERCALCAEMIA] were greatly relieved, especially by [APD].","0"
"2126","TWrex-treat","[ITP]","56","59","[ANTIBODY]","115","123","The diagnosis of antiphospholipid syndrome, rather than [ITP], was made because of anticardiolipin-beta 2GPI complex [ANTIBODY] and cerebral infarction.","0"
"2127","TWrex-treat","[HYPOGLYCEMIA]","135","147","[GLUCOSE]","98","105","The study aim was to investigate the effect of the route of insulin treatment on the glucagon and [GLUCOSE] production (GP) responses to [HYPOGLYCEMIA] in the diabetic rat.","0"
"2128","TWrex-treat","[ULCERATIVE COLITIS]","73","91","[HYDROCORTISONE]","55","69","The effectiveness of intravenous corticotrophin versus [HYDROCORTISONE] in [ULCERATIVE COLITIS] has been determined including whether previous steroid therapy influenced the better response to one rather than the other, but no such studies have ever been done in Crohn's disease.","0"
"2129","TWrex-treat","[SHOCK]","86","91","[DEXTRAN]","44","51","Pathophysiologic mechanisms involved in the [DEXTRAN] effect on mortality in intestinal [SHOCK] in rats were studied, using a standardized model for intestinal vascular obstruction.","0"
"2132","TWrex-treat","[BLEEDING]","100","108","[CIMETIDINE]","180","190","In 97 consecutive patients undergoing renal transplantation the incidence of upper gastrointestinal [BLEEDING] was registered over 180 days after allocation to treatment with either [CIMETIDINE] or placebo.","0"
"2133","TWrex-treat","[CARDIAC ARRHYTHMIA]","7","25","[ANTIARRHYTHMIC DRUG]","238","257","In the [CARDIAC ARRHYTHMIA] Pilot Study (CAPS), patients early (6-60 days) after acute myocardial infarction (MI) with ventricular premature complexes (VPCs) of over 10 per hour were randomized to receive, unaware, therapy with one of four [ANTIARRHYTHMIC DRUG]s (n = 402) or placebo (n = 100.","0"
"2134","TWrex-treat","[INFARCTION]","146","156","[STREPTOKINASE]","100","113","Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) and anisoylated plasminogen [STREPTOKINASE] activator (APSAC) in myocardial [INFARCTION] has been proved to reduce mortality.","0"
"2136","TWrex-treat","[HEART FAILURE]","141","154","[ISOSORBIDE]","40","50","These data suggest that hydralazine and [ISOSORBIDE] dinitrate do not improve skeletal muscle oxygen delivery during exercise in patients with [HEART FAILURE].","0"
"2137","TWrex-treat","[SYSTEMIC LUPUS ERYTHEMATOSUS]","29","57","[HYDROXYCHLOROQUINE]","260","278","Demographic characteristics, [SYSTEMIC LUPUS ERYTHEMATOSUS] Disease Activity Index (SLEDAI) and Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI) were assessed as well as administration, maximum dose and cumulative dose of prednisone and [HYDROXYCHLOROQUINE] (HCQ.","0"
"2138","TWrex-treat","[ARRHYTHMIA]","40","50","[ANTIARRHYTHMIC DRUG]","67","86","Patients who have malignant ventricular [ARRHYTHMIA]s and respond to [ANTIARRHYTHMIC DRUG] treatment are proven to have a much lower mortality than those who do not.","0"
"2139","TWrex-treat","[LEUKEMIA]","103","111","[FLUDARABINE]","171","182","We explored the relationship between the cytogenetic/biologic characteristics of B-chronic lymphocytic [LEUKEMIA] (B-CLL) cells and their tendency to undergo spontaneous or [FLUDARABINE]-induced apoptosis in vitro.","0"
"2140","TWrex-treat","[DIABETES]","128","136","[INSULIN]","13","20","CONCLUSIONS: [INSULIN] glargine substantially improved glycemic control in children and adolescents with poorly controlled type 1 [DIABETES].","0"
"2141","TWrex-treat","[ATRIAL FIBRILLATION]","94","113","[WARFARIN]","68","76","Left atrium appendage (LAA) occlusion is a potential alternative to [WARFARIN] in patients with [ATRIAL FIBRILLATION] who have contraindications to anticoagulation.","0"
"2143","TWrex-treat","[PAIN]","9","13","[PARACETAMOL]","67","78","At a low [PAIN] level the initial treatment is acetylsalicylic acid, [PARACETAMOL] or other nonsteroidal antiinflammatory drugs.","0"
"2144","TWrex-treat","[CANCER]","41","47","[CISPLATIN]","83","92","Thirty-one patients with small-cell lung [CANCER] (SCLC) were treated with VP-16 and [CISPLATIN] as first-line therapy.","0"
"2145","TWrex-treat","[AUTOIMMUNE HAEMOLYTIC ANAEMIA]","4","33","[INTRAVENOUS IMMUNOGLOBULIN]","196","222","The [AUTOIMMUNE HAEMOLYTIC ANAEMIA] (AIHA) and immune thrombocytopenic purpura (ITP) were refractory to conventional immunosuppressive therapy which included steroids, azathioprine, vincristine and [INTRAVENOUS IMMUNOGLOBULIN].","0"
"2146","TWrex-treat","[STONE]","56","61","[ACID]","124","128","In a five year study, 55 patients with radiolucent gall [STONE]s were treated with the combination of 7.5 mg chenodeoxycholic [ACID] (CDCA) and 5.0 mg ursodeoxycholic acid (UDCA)/kg/day--that is, half the monotherapeutic doses.","0"
"2147","TWrex-treat","[STONE]","56","61","[ACID]","163","167","In a five year study, 55 patients with radiolucent gall [STONE]s were treated with the combination of 7.5 mg chenodeoxycholic acid (CDCA) and 5.0 mg ursodeoxycholic [ACID] (UDCA)/kg/day--that is, half the monotherapeutic doses.","0"
"2148","TWrex-treat","[ANGINA]","51","57","[ISDN]","38","42","These results suggest the efficacy of [ISDN] tape on [ANGINA] pectoris, especially in its durability of action which lasts over 24 h.","0"
"2149","TWrex-treat","[CA]","14","16","[EPINEPHRINE]","96","107","The increased [CA] levels were mainly due to a rise in NE in stable hypertension and to a rise in [EPINEPHRINE] (E) in labile hypertension.","0"
"2150","TWrex-treat","[NTD]","48","51","[FOLIC ACID]","88","98","Studies on women with previous pregnancies with [NTD] showed that supplementary intake of [FOLIC ACID], with or without other vitamins, preconceptual period throughout the first trimester has a preventive effect on its recurrence.","0"
"2151","TWrex-treat","[CHRONIC MYELOID LEUKEMIA]","44","68","[BU]","4","6","The [BU]-Cy regimen has shown an advantage in [CHRONIC MYELOID LEUKEMIA] and TBI-Cy remains the standard conditioning regimen in acute lymphoblastic leukemia, but results are more conflicting in acute myeloid leukemia (AML.","0"
"2152","TWrex-treat","[CHRONIC MYELOID LEUKEMIA]","44","68","[BU]","155","157","The Bu-Cy regimen has shown an advantage in [CHRONIC MYELOID LEUKEMIA] and TBI-Cy remains the standard conditioning regimen in acute lymphoblastic leukemia, [BU]t results are more conflicting in acute myeloid leukemia (AML.","0"
"2153","TWrex-treat","[NIDDM]","126","131","[INSULIN]","89","96","Gestational diabetes mellitus (GDM) constitutes a risk factor for the development of non [INSULIN]-dependent diabetes mellitus ([NIDDM].","0"
"2154","TWrex-treat","[AMENORRHOEA]","105","116","[LHRH]","25","29","To monitor the effect of [LHRH] treatment on hypothalamo-pituitary-gonadal function, women with functional [AMENORRHOEA] were investigated by standardized LHRH and repeated clomiphene tests before and after LHRH therapy.","0"
"2155","TWrex-treat","[AMENORRHOEA]","105","116","[LHRH]","151","155","To monitor the effect of LHRH treatment on hypothalamo-pituitary-gonadal function, women with functional [AMENORRHOEA] were investigated by standardized [LHRH] and repeated clomiphene tests before and after LHRH therapy.","0"
"2156","TWrex-treat","[AMENORRHOEA]","105","116","[LHRH]","203","207","To monitor the effect of LHRH treatment on hypothalamo-pituitary-gonadal function, women with functional [AMENORRHOEA] were investigated by standardized LHRH and repeated clomiphene tests before and after [LHRH] therapy.","0"
"2157","TWrex-treat","[HYPERGLYCEMIA]","5","18","[INSULIN]","36","43","When [HYPERGLYCEMIA] supervenes, both [INSULIN] secretion and insulin-mediated glucose utilization are further compromised, mediated in part by sustained hyperglycemia itself.","0"
"2158","TWrex-treat","[HYPERGLYCEMIA]","5","18","[INSULIN]","58","65","When [HYPERGLYCEMIA] supervenes, both insulin secretion and [INSULIN]-mediated glucose utilization are further compromised, mediated in part by sustained hyperglycemia itself.","0"
"2159","TWrex-treat","[HYPERGLYCEMIA]","150","163","[INSULIN]","36","43","When hyperglycemia supervenes, both [INSULIN] secretion and insulin-mediated glucose utilization are further compromised, mediated in part by sustained [HYPERGLYCEMIA] itself.","0"
"2160","TWrex-treat","[HYPERGLYCEMIA]","150","163","[INSULIN]","58","65","When hyperglycemia supervenes, both insulin secretion and [INSULIN]-mediated glucose utilization are further compromised, mediated in part by sustained [HYPERGLYCEMIA] itself.","0"
"2161","TWrex-treat","[INFECTION]","141","150","[CEFOXITIN]","91","100","A single 2 g preoperative dose of cefotetan was as safe and effective as multiple doses of [CEFOXITIN] in the reduction of postoperative wound [INFECTION]s after colorectal surgery.","0"
"2162","TWrex-treat","[DIABETES]","27","35","[INSULIN]","62","69","The pathogenesis of type 2 [DIABETES] involves abnormalities in [INSULIN] action, insulin secretion, and endogenous glucose output (EGO.","0"
"2163","TWrex-treat","[DIABETES]","27","35","[INSULIN]","78","85","The pathogenesis of type 2 [DIABETES] involves abnormalities in insulin action, [INSULIN] secretion, and endogenous glucose output (EGO.","0"
"2164","TWrex-treat","[LYMPHOMA]","118","126","[MITOZANTRONE]","77","89","This report compares a pilot study followed by a trial of the combination of [MITOZANTRONE] and ifosfamide for relapsed [LYMPHOMA].","0"
"2167","TWrex-treat","[TYPE 2 DIABETES]","80","95","[PIOGLITAZONE]","0","12","[PIOGLITAZONE] also had a beneficial effect on the abnormal lipid profile seen in [TYPE 2 DIABETES].","0"
"2168","TWrex-treat","[THROMBOEMBOLISM]","55","70","[HEPARIN]","128","135","We report here a case of recurrent venous and arterial [THROMBOEMBOLISM], Trousseau's syndrome, in a cancer patient who developed [HEPARIN]-induced thrombocytopenia.","0"
"2169","TWrex-treat","[HBV]","108","111","[HBSAG]","33","38","Since the infectivity of chronic [HBSAG] carriers is falling with time, the researchers submit that long-term [HBV] vaccination is reducing hbv transmission in Keneba and Manduar.","0"
"2170","TWrex-treat","[HBV]","136","139","[HBSAG]","33","38","Since the infectivity of chronic [HBSAG] carriers is falling with time, the researchers submit that long-term hbv vaccination is reducing [HBV] transmission in Keneba and Manduar.","0"
"2171","TWrex-treat","[PARKINSON'S DISEASE]","57","76","[L-DOPA]","37","43","Among the catechol drugs used in the [L-DOPA] treatment of [PARKINSON'S DISEASE], the COMT inhibitors entacapone and tolcapone were not methylated, whereas the DOPA decarboxylase inhibitor benserazide was 15 times more specific substrate than L-DOPA, the target of COMT inhibition.","0"
"2172","TWrex-treat","[PARKINSON'S DISEASE]","57","76","[L-DOPA]","239","245","Among the catechol drugs used in the L-DOPA treatment of [PARKINSON'S DISEASE], the COMT inhibitors entacapone and tolcapone were not methylated, whereas the DOPA decarboxylase inhibitor benserazide was 15 times more specific substrate than [L-DOPA], the target of COMT inhibition.","0"
"2173","TWrex-treat","[DUODENAL ULCER DISEASE]","233","255","[RANITIDINE]","152","162","The effect on intragastric pH of two different dose regimens of continuous intravenous infusion of omeprazole (4 or 8 mg/h after a bolus of 80 mg), and [RANITIDINE] (0.25 mg/kg/h after a bolus of 50 mg) was studied in 10 patients with [DUODENAL ULCER DISEASE] in symptomatic remission.","0"
"2176","TWrex-treat","[PAIN]","110","114","[ASPIRIN]","92","99","The procedure is illustrated using a meta-analysis of the effectiveness of single-dose oral [ASPIRIN] for acute [PAIN], and results are also obtained for five other meta-analyses.","0"
"2177","TWrex-treat","[OVERLOAD]","5","13","[DEFEROXAMINE]","165","177","Iron [OVERLOAD] was evaluated for 26 beta-thalassemia homozygous patients, and 14 of them were submitted to intensive chelation therapy with high doses of intravenous [DEFEROXAMINE] (DF.","0"
"2178","TWrex-treat","[HYPOGLYCEMIA]","138","150","[GLUCOSE]","95","102","Insulin glargine should be considered for patients who continue to have elevated morning blood [GLUCOSE] levels and problems with nocturnal [HYPOGLYCEMIA] despite receiving NPH insulin at bedtime.","0"
"2179","TWrex-treat","[NEURAL TUBE DEFECT]","237","255","[FOLIC ACID]","130","140","In a series of nonrandomized and randomized intervention trials and case-control and cohort studies, women using multivitamins or [FOLIC ACID] supplements during the first 6 weeks of pregnancy experienced a three- to fourfold reduction in [NEURAL TUBE DEFECT]s among their offspring.","0"
"2180","TWrex-treat","[HYPERTENSION]","246","258","[FUROSEMIDE]","47","57","These data show that an acute stimulation with [FUROSEMIDE] and ambulation affects mainly the active form of plasma renin, and that the effect of age on inactive plasma renin in normal subjects may be different from that in patients with essential [HYPERTENSION].","0"
"2181","TWrex-treat","[PARKINSON'S DISEASE]","180","199","[SELEGILINE]","11","21","Both Zydis [SELEGILINE] (1.25 mg and 10 mg) treatments were shown to be therapeutically equivalent to conventional selegiline tablets 10 mg based on comparison of mean total Unified [PARKINSON'S DISEASE] Rating Scale (UPDRS) scores.","0"
"2182","TWrex-treat","[PARKINSON'S DISEASE]","180","199","[SELEGILINE]","113","123","Both Zydis Selegiline (1.25 mg and 10 mg) treatments were shown to be therapeutically equivalent to conventional [SELEGILINE] tablets 10 mg based on comparison of mean total Unified [PARKINSON'S DISEASE] Rating Scale (UPDRS) scores.","0"
"2183","TWrex-treat","[HEPATITIS]","87","96","[ANTIGEN]","107","114","Representative samples of each species were tested by solid phase radioimmunoassay for [HEPATITIS] B surface [ANTIGEN] (HBSAg, Australia antigen.","0"
"2184","TWrex-treat","[HEPATITIS]","87","96","[ANTIGEN]","133","140","Representative samples of each species were tested by solid phase radioimmunoassay for [HEPATITIS] B surface antigen (HBSAg, Australia [ANTIGEN].","0"
"2185","TWrex-treat","[VAGINOSIS]","10","19","[METRONIDAZOLE]","121","134","Bacterial [VAGINOSIS] was eradicated in 93% of women using intravaginal clindamycin and in 87% of women using intravaginal [METRONIDAZOLE].","0"
"2189","TWrex-treat","[NSCLC]","161","166","[DOCETAXEL]","129","138","For example, the overall objective response rate of 9.5% with single agent sunitinib compares similarly to that of pemetrexed or [DOCETAXEL] in previously treated [NSCLC] patients, but toxicity, notably fatigue, lead to discontinuation in 38% of patients.","0"
"2190","TWrex-treat","[MYOCARDIAL INFARCTION]","220","241","[STREPTOKINASE]","150","163","The purpose of this study was to investigate whether, to what extent, and through which mechanisms intravenous heparin, administered before and after [STREPTOKINASE], affects the plasma levels of D-dimer and fibrinogen in [MYOCARDIAL INFARCTION].","0"
"2191","TWrex-treat","[ANEMIA]","46","52","[IRON]","30","34","A relatively low incidence of [IRON] deficiency [ANEMIA] and high incidence of exhausted iron reserves in the women living in the high mountains indicates the participation of the adaptive-compensatory mechanisms in the development of iron-deficiency.","0"
"2192","TWrex-treat","[ANEMIA]","46","52","[IRON]","85","89","A relatively low incidence of iron deficiency [ANEMIA] and high incidence of exhausted [IRON] reserves in the women living in the high mountains indicates the participation of the adaptive-compensatory mechanisms in the development of iron-deficiency.","0"
"2193","TWrex-treat","[ANEMIA]","46","52","[IRON]","231","235","A relatively low incidence of iron deficiency [ANEMIA] and high incidence of exhausted iron reserves in the women living in the high mountains indicates the participation of the adaptive-compensatory mechanisms in the development of [IRON]-deficiency.","0"
"2194","TWrex-treat","[ASTHMA]","135","141","[SODIUM]","76","82","In a double-blind, crossover study we investigated the effect of nedocromil [SODIUM] on NKA-induced bronchoconstriction in subjects with [ASTHMA].","0"
"2195","TWrex-treat","[T2D]","246","249","[INSULIN]","114","121","In conclusion, the discovery of calpain-10 by a genetic approach has identified it as a molecule of importance to [INSULIN] signaling and secretion that may have relevance to the future development of novel therapeutic targets for the treatment of [T2D].","0"
"2196","TWrex-treat","[SALMONELLA]","15","25","[NALIDIXIC ACID]","252","266","Ten strains of [SALMONELLA] weltevreden isolated from poultry sources were examined and found to contain plasmid DNA ranging in size from 1.8 to 68.5 MD. All isolates were susceptible to carbenicillin, cephalothin, ceftriazone, gentamicin, kanamycin and [NALIDIXIC ACID], but resistance to bacitracin (100%), penicillin G (100%), rifampicin (100%), sulphamethoxazole (100%), cefuroxime (80%) and tetracycline (60%) was recorded.","0"
"2199","TWrex-treat","[DRUG TOXICITY]","206","219","[CHARCOAL]","78","86","It is suggested that the optimal regimen for the use of repeat dose activated [CHARCOAL] in acute drug intoxications is an initial dose of 75-100 g, followed by 50 g every 4 hours until the risks of systemic [DRUG TOXICITY] are reduced to an acceptable level.","0"
"2200","TWrex-treat","[TETANUS]","78","85","[TETANUS TOXOID]","47","61","Three groups of horses were injected; one with [TETANUS TOXOID] alone, one with [TETANUS] antitoxin alone and one in which the tetanus toxoid and tetanus antitoxin were injected simultaneously.","0"
"2201","TWrex-treat","[TETANUS]","78","85","[TETANUS TOXOID]","123","137","Three groups of horses were injected; one with tetanus toxoid alone, one with [TETANUS] antitoxin alone and one in which the [TETANUS TOXOID] and tetanus antitoxin were injected simultaneously.","0"
"2202","TWrex-treat","[TETANUS]","123","130","[TETANUS TOXOID]","47","61","Three groups of horses were injected; one with [TETANUS TOXOID] alone, one with tetanus antitoxin alone and one in which the [TETANUS] toxoid and tetanus antitoxin were injected simultaneously.","0"
"2203","TWrex-treat","[TETANUS]","142","149","[TETANUS TOXOID]","47","61","Three groups of horses were injected; one with [TETANUS TOXOID] alone, one with tetanus antitoxin alone and one in which the tetanus toxoid and [TETANUS] antitoxin were injected simultaneously.","0"
"2204","TWrex-treat","[TETANUS]","142","149","[TETANUS TOXOID]","123","137","Three groups of horses were injected; one with tetanus toxoid alone, one with tetanus antitoxin alone and one in which the [TETANUS TOXOID] and [TETANUS] antitoxin were injected simultaneously.","0"
"2205","TWrex-treat","[TUBERCULOSIS]","74","86","[RIFAMPICIN]","25","35","A new method for testing [RIFAMPICIN] (RFP) susceptibility of Mycobacterium [TUBERCULOSIS] was developed.","0"
"2206","TWrex-treat","[MALIGNANT MELANOMA]","160","178","[IFN]","135","138","To our knowledge this is the first report that demonstrates histological abnormalities of the glomerulus associated with postoperative [IFN]-beta therapy for the [MALIGNANT MELANOMA].","0"
"2209","TWrex-treat","[DEPRESSION]","83","93","[KAVA]","98","102","Whereas St. John's wort extracts are prescribed for the treatment of mild forms of [DEPRESSION] and [KAVA]-kava for unspecified anxiety syndromes, hop, balm, lavender, passiflora and valerian are traditionally administered against nervousness and sleep disturbances.","0"
"2210","TWrex-treat","[DEPRESSION]","83","93","[KAVA]","103","107","Whereas St. John's wort extracts are prescribed for the treatment of mild forms of [DEPRESSION] and kava-[KAVA] for unspecified anxiety syndromes, hop, balm, lavender, passiflora and valerian are traditionally administered against nervousness and sleep disturbances.","0"
